Showing results (401-410 of 606) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|May 17, 2023
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRebecca Bresnahan, Rachel Houten, Janette Greenhalgh, et al.
Pharmacoeconomics - Open|April 16, 2021
State-Level Variations and Factors Associated with Adult Vaccination Coverage: A Multilevel Modeling ApproachDiana Garbinsky, Shannon Hunter, Elizabeth M La, et al.
Pharmacoeconomics - Open|November 12, 2025
Cost of Chronic Heart Failure Among Adult Europeans-A Systematic Literature ReviewAlexandra Mincă, Claudiu C Popescu, Dragoş I Mincă, et al.
Pharmacoeconomics - Open|July 20, 2025
Economic Evaluation of Lecanemab for Early Symptomatic Alzheimer's Disease in South KoreaSeungyeon Shin, Maryanne Kim, Song Hee Hong
Pharmacoeconomics - Open|July 25, 2025
Cost-Effectiveness of an Insertable Cardiac Arrhythmia Monitor after Non-ST-Elevation Myocardial Infarction in the UKAmy Dymond, E Barker, N Tsitiridis, et al.
Pharmacoeconomics - Open|September 18, 2025
A Budget Impact Model of Treatment of Primary Immune Deficiency with Immune Globulin Subcutaneous (Human), 20% (IgPro20) (Hizentra)Rajiv Mallick, Rashad Carlton
Pharmacoeconomics - Open|June 16, 2025
Real-World Analysis of Healthcare Utilization, Treatment Patterns, and Economic Burden in Medicare Beneficiaries with Parkinson's Disease: Implications by Levodopa Formulation and Disease SeverityRenée J G Arnold, Winona Tse, Kimberly Martin, et al.
Pharmacoeconomics - Open|May 30, 2025
Cost-Effectiveness Analyses of Adolescent- and Young-Adult-Focused HIV Interventions Incorporating HIV Transmission: a Scoping Review of Modeling Methods and Proposed GuidanceWanyi Chen, Simeng Li, Carol Mita, et al.
Pharmacoeconomics - Open|July 12, 2024
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in ArgentinaNatalia Espinola, Constanza Silvestrini, Carla Colaci, et al.
Pharmacoeconomics - Open|July 2, 2024
Comparison of Two Financial Incentives to Encourage the Use of Adalimumab Biosimilars: Results of a French Experiment Close to CliniciansMarion Tano, Pascal Paubel, Matthieu Ribault, et al.
Pageof 61